UB Paderborn / Katalog / Suche / in CDI

Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.

1 – 25 von 158

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis

Annual review of nutrition, 2016-07, Vol.36 (1), p.275-299

2016

Volltextzugriff (PDF)

Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr−/− mice

Journal of lipid research, 2018-09, Vol.59 (9), p.1714-1728

2018

Volltextzugriff (PDF)

Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically

Arteriosclerosis, thrombosis, and vascular biology, 2016-12, Vol.36 (12), p.2439-2445

2016

Volltextzugriff (PDF)

Antiatherogenic properties of flavonoids: Implications for cardiovascular health

Canadian journal of cardiology, 2010-03, Vol.26, p.17A-21A

2010

Volltextzugriff (PDF)

Nobiletin Prevents High-Fat Diet-Induced Dysregulation of Intestinal Lipid Metabolism and Attenuates Postprandial Lipemia

Arteriosclerosis, thrombosis, and vascular biology, 2022-02, Vol.42 (2), p.127-144

2022

Volltextzugriff (PDF)

The citrus flavonoid nobiletin confers protection from metabolic dysregulation in high-fat-fed mice independent of AMPK[S]

Journal of lipid research, 2020-03, Vol.61 (3), p.387-402

2020

Volltextzugriff (PDF)

Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance

Diabetes (New York, N.Y.), 2009-10, Vol.58 (10), p.2198-2210

2009

Volltextzugriff (PDF)

Naringenin Prevents Obesity, Hepatic Steatosis, and Glucose Intolerance in Male Mice Independent of Fibroblast Growth Factor 21

Endocrinology (Philadelphia), 2015-06, Vol.156 (6), p.2087-2102

2015

Volltextzugriff (PDF)

Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr−/− mice[S]

Journal of lipid research, 2013-03, Vol.54 (3), p.711-724

2013

Volltextzugriff (PDF)

Fibroblast Growth Factor 21 Reduces the Severity of Cerulein-Induced Pancreatitis in Mice

Gastroenterology (New York, N.Y. 1943), 2009-11, Vol.137 (5), p.1795-1804

2009

Volltextzugriff (PDF)

Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice

Arteriosclerosis, thrombosis, and vascular biology, 2010-04, Vol.30 (4), p.742-748

2010

Volltextzugriff (PDF)

PPARδ activation attenuates hepatic steatosis in Ldlr−/− mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity

Journal of lipid research, 2014-07, Vol.55 (7), p.1254-1266

2014

Volltextzugriff (PDF)

ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia

Current opinion in lipidology, 2017-04, Vol.28 (2), p.193-200

2017

Volltextzugriff (PDF)

Citrus flavonoids and lipid metabolism

Current opinion in lipidology, 2013-02, Vol.24 (1), p.34-40

2013

Volltextzugriff (PDF)

Bempedoic acid: effects on lipoprotein metabolism and atherosclerosis

Current opinion in lipidology, 2019-02, Vol.30 (1), p.1-9

2019

Volltextzugriff (PDF)

molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin

Journal of lipid research, 2007-03, Vol.48 (3), p.699-708

2007

Volltextzugriff (PDF)

NPC1L1: evolution from pharmacological target to physiological sterol transporter

Arteriosclerosis, thrombosis, and vascular biology, 2006-11, Vol.26 (11), p.2433-2438

2006

Volltextzugriff (PDF)

Selective Up-regulation of LXR-regulated Genes ABCA1, ABCG1, and APOE in Macrophages through Increased Endogenous Synthesis of 24(S),25-Epoxycholesterol

The Journal of biological chemistry, 2007-02, Vol.282 (8), p.5207-5216

2007

Volltextzugriff (PDF)

Citrus Flavonoids and the Prevention of Atherosclerosis

Cardiovascular & hematological disorders drug targets, 2012-12, Vol.12 (2), p.84-91

2012

Volltextzugriff (PDF)

Inhibition of Microsomal Triglyceride Transfer Protein Expression and Apolipoprotein B100 Secretion by the Citrus Flavonoid Naringenin and by Insulin Involves Activation of the Mitogen-Activated Protein Kinase Pathway in Hepatocytes

Diabetes (New York, N.Y.), 2005-06, Vol.54 (6), p.1676-1683

2005

Volltextzugriff (PDF)

Lipid Incorporation Inhibits Src-Dependent Assembly of Fibronectin and Type I Collagen by Vascular Smooth Muscle Cells

Circulation research, 2009-04, Vol.104 (7), p.832-841

2009

Volltextzugriff (PDF)

Peroxisome proliferator-activated receptor δ: a multifaceted metabolic player

Current opinion in lipidology, 2013-04, Vol.24 (2), p.171-177

2013

Volltextzugriff (PDF)

Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid Oxidation

PPAR Research, 2012-01, Vol.2012 (2012), p.770-778

2012

Volltextzugriff (PDF)

Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP

Journal of lipid research, 2001-05, Vol.42 (5), p.725-734

2001

Volltextzugriff (PDF)

Apolipoprotein C-III: Going Back to the Future for a Lipid Drug Target

Circulation research, 2013-05, Vol.112 (11), p.1405-1408

2013

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(107)

Sprache

Englisch
(158)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis

Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr−/− mice

Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically

Antiatherogenic properties of flavonoids: Implications for cardiovascular health

Nobiletin Prevents High-Fat Diet-Induced Dysregulation of Intestinal Lipid Metabolism and Attenuates Postprandial Lipemia

The citrus flavonoid nobiletin confers protection from metabolic dysregulation in high-fat-fed mice independent of AMPK[S]

Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance

Naringenin Prevents Obesity, Hepatic Steatosis, and Glucose Intolerance in Male Mice Independent of Fibroblast Growth Factor 21

Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr−/− mice[S]

Fibroblast Growth Factor 21 Reduces the Severity of Cerulein-Induced Pancreatitis in Mice

Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice

PPARδ activation attenuates hepatic steatosis in Ldlr−/− mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity

ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia

Citrus flavonoids and lipid metabolism

Bempedoic acid: effects on lipoprotein metabolism and atherosclerosis

molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin

NPC1L1: evolution from pharmacological target to physiological sterol transporter

Selective Up-regulation of LXR-regulated Genes ABCA1, ABCG1, and APOE in Macrophages through Increased Endogenous Synthesis of 24(S),25-Epoxycholesterol

Citrus Flavonoids and the Prevention of Atherosclerosis

Inhibition of Microsomal Triglyceride Transfer Protein Expression and Apolipoprotein B100 Secretion by the Citrus Flavonoid Naringenin and by Insulin Involves Activation of the Mitogen-Activated Protein Kinase Pathway in Hepatocytes

Lipid Incorporation Inhibits Src-Dependent Assembly of Fibronectin and Type I Collagen by Vascular Smooth Muscle Cells

Peroxisome proliferator-activated receptor δ: a multifaceted metabolic player

Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid Oxidation

Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP

Apolipoprotein C-III: Going Back to the Future for a Lipid Drug Target

Aktive Filter

Suchergebnisse filtern